Direct oral anticoagulants
166 results
138 - 166
Extended rivaroxaban prophylaxis following a medical inpatient stay does not provide a net benefit (MARINER)- A new bleeding risk score predicts major bleeding better than other scores in elderly patients who take DOACs
- Warfarin provides greater net benefit than rivaroxaban for patients with atrial fibrillation and rheumatic heart disease
- ACG guideline on managing acute lower gastrointestinal bleeding
- Optimal treatment of acute venous thromboembolism
Heparin for the prevention of venous thromboembolism in acutely ill medical patients (excluding stroke and myocardial infarction): Cochrane systematic review- Primary prophylaxis for venous thromboembolism in patients undergoing cardiac or thoracic surgery
Assessment and treatment of a patient with bleeding diathesis - Antithrombotic therapy for ambulatory patients with multiple myeloma receiving immunomodulatory agents
- Updated American College of Chest Physicians guideline on antithrombotic therapy for venous thromboembolism
- Prevention of venous thromboembolism
- Systemic lupus erythematosus (SLE)
- Electrical cardioversion
- Continuous intravenous perioperative lidocaine infusion for postoperative pain and recovery in adults: Cochrane systematic review
- Home versus in‐patient treatment for deep vein thrombosis
- Anticoagulation for the long term treatment of venous thromboembolism in patients with cancer
- Deep vein thrombosis
- Pharmacological interventions for preventing venous thromboembolism in people undergoing bariatric surgery
- Prophylaxis of thromboembolism during therapy with asparaginase in adults with acute lymphoblastic leukaemia
- Lumbar puncture
- Management of acute atrial fibrillation
- Acute coronary syndrome
- Interrupted versus uninterrupted anticoagulation for cardiac rhythm management device insertion
- Cerebral infarction (ischaemic stroke)
- COVID-19 and other coronavirus infections